Identification of mutations associated with acquired resistance to sunitinib in renal cell cancer
Keywords: 
Materias Investigacion::Ciencias de la Salud::Urología y nefrología
Sunitinib
Renal cell carcinoma
Biomarkers
Resistance
MCL-1
mTORC1
G6PD
LRP1B
SETD2
TET2
SYNE1
DCC
Issue Date: 
2019
Publisher: 
UICC
ISSN: 
0020-7136
Note: 
Artículo bajo licencia Creative Commons
Citation: 
Elgendy, M. (Mohamed); Fusco, J.P. (Juan Pablo); Segura, V. (Víctor); et al. "Identification of mutations associated with acquired resistance to sunitinib in renal cell cancer". International Journal of Cancer. 145, 2019, 1991 - 2001
Abstract
Sunitinib is one of the most widely used targeted therapeutics for renal cell carcinoma (RCC), but acquired resistance against targeted therapies remains a major clinical challenge. To dissect mechanisms of acquired resistance and unravel reliable predictive biomarkers for sunitinib in RCC, we sequenced the exons of 409 tumor-suppressor genes and oncogenes in paired tumor samples from an RCC patient, obtained at baseline and after development of acquired resistance to sunitinib. From newly arising mutations, we selected, using in silico prediction models, six predicted to be deleterious, located in G6PD, LRP1B, SETD2, TET2, SYNE1, and DCC. Consistently, immunoblotting analysis of lysates derived from sunitinib-desensitized RCC cells and their parental counterparts showed marked differences in the levels and expression pattern of the proteins encoded by these genes. Our further analysis demonstrates essential roles for these proteins in mediating sunitinib cytotoxicity and shows that their loss of function renders tumor cells resistant to sunitinib in vitro and in vivo. Finally, sunitinib resistance induced by continuous exposure or by inhibition of the six proteins was overcome by treatment with cabozantinib or a low-dose combination of lenvatinib and everolimus. Collectively, our results unravel novel markers of acquired resistance to sunitinib and clinically relevant approaches for overcoming this resistance in RCC.

Files in This Item:
Thumbnail
File
Identification of mutations associated with acquired resistance to sunitinib in (1).pdf
Description
Size
4.62 MB
Format
Adobe PDF


Statistics and impact

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.